DIST_0210_scitranslmed.abc6894

Trastuzumab-RNA polymerase inhibitor conjugate for breast cancer with low HER2 expression

By Claire Quang, Staff Writer

Feb 27, 2021 | 1:08 AM GMT

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

An antibody-drug conjugate comprising anti-HER2 antibody trastuzumab

Read the full 278 word article

How to gain access

Continue reading with a
two-week free trial.